4th Annual Meeting, American Society of Gene Therapy
美国基因治疗学会第四届年会
基本信息
- 批准号:6368364
- 负责人:
- 金额:$ 3.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-06 至 2002-06-05
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): For gene therapy it has been the best of
times and the worst of times. Rarely a technology in medicine has undergone
such scrutiny, partly because of the broad promise that this field holds. The
tragedy of young Gelsinger is partly offset by the successes in children with
SCID (severe combined immunodeficiency) who are now enjoying a normal
childhood. Additionally, there are promising and encouraging results on the
treatment of hemophilia and certain types of cancer. There are also exciting
new results in several pre-clinical models. The American Society of Gene
Therapy (ASGT) will hold its 4th annual meeting in Seattle, Washington from May
31-June 3, 2001, to discuss the latest and exciting results in the field of
gene therapy. The three and a half day meeting will include 3 keynote
addresses, 9-10 symposia (4 speakers/symposia), presidential symposia, special
symposia on future biology, 20 colloquia (selected from submitted abstracts),
10-15 workshops (6-8 speakers/workshop), 20 education seminars, 20
meet-the-professor sessions, 3 days of poster viewing, high school
student/teacher outreach program, public education, and corporate symposia. The
general areas covered in the meeting will be gene therapy approaches to
cardiovascular disease, cancer, genetic diseases, infectious diseases,
musculo-skeletal disorders, neuronal disorders, and hematopoiesis. The
workshops are designed to discuss the improvements in delivery systems,
production of vectors, novel vector systems, and specific diseases. The
education program is to acquaint the attendees of general areas of gene therapy
to broaden their horizons. The "meet-the-professor" sessions are designed to
promote interaction among young investigators and faculty members. Young
scientists working in the field of gene therapy will have opportunities to
present their work in colloquia and at the poster sessions. Based on the 3rd
ASGT meeting and a recent increase in membership, we expect nearly 2,500-3,000
participants. We have planned a program where 10-15 percent of the participants
will have an opportunity to make oral presentations. Because of the breadth and
wide scope of gene therapy, we seek "cross-institutional support" for the
meeting from the NIH, including, but not limited to NHLBI, OD, NCI, NEI, NHGRJ,
NIA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIGMS, NIMH, and NINDS. Emphasis on
education and extensive participation of young practitioners in the field, give
the annual ASGT meeting a unique niche. Indeed, in just four years, the annual
ASGT meeting has become "the premier scientific meeting in gene therapy."
描述(由申请人提供):对于基因治疗,它是最好的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
INDER Mohan VERMA其他文献
INDER Mohan VERMA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('INDER Mohan VERMA', 18)}}的其他基金
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas
恶性胶质瘤的分子机制和治疗方法
- 批准号:
9187795 - 财政年份:2015
- 资助金额:
$ 3.25万 - 项目类别:
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS
病毒载体诱导的胶质母细胞瘤的多尺度表征
- 批准号:
8361918 - 财政年份:2011
- 资助金额:
$ 3.25万 - 项目类别:
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS
病毒载体诱导的胶质母细胞瘤的多尺度表征
- 批准号:
8169618 - 财政年份:2010
- 资助金额:
$ 3.25万 - 项目类别:
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS
病毒载体诱导的胶质母细胞瘤的多尺度表征
- 批准号:
7957628 - 财政年份:2009
- 资助金额:
$ 3.25万 - 项目类别:
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS
病毒载体诱导的胶质母细胞瘤的多尺度表征
- 批准号:
7722462 - 财政年份:2008
- 资助金额:
$ 3.25万 - 项目类别:
NHF Fifth Workshop on Gene Therapies for Hemophilia
NHF 第五届血友病基因治疗研讨会
- 批准号:
6507846 - 财政年份:2002
- 资助金额:
$ 3.25万 - 项目类别: